The Vanguard Group 13D and 13G filings for Maravai LifeSciences Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:08 pm Sale |
2023-12-29 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
The Vanguard Group | 10,003,894 7.570% |
-386,085 (-3.72%) |
Filing |
| 2023-02-09 11:25 am Sale |
2022-12-30 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
The Vanguard Group | 10,389,979 7.900% |
-143,630 (-1.36%) |
Filing |
| 2022-02-10 08:22 am Purchase |
2021-12-31 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
The Vanguard Group | 10,533,609 8.010% |
5,820,157 (+123.48%) |
Filing |
| 2021-02-10 11:22 am Purchase |
2020-12-31 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
The Vanguard Group | 4,713,452 5.300% |
4,713,452 (New Position) |
Filing |